An Evaluation of the Expression of SCC-Ag,PD-L1 and RRM1 on the Efficacy of Chemotherapy in Patients with Intermediate and Advanced Lung Squamous Cell Carcinoma and Analysis of Its Relationship with Prognosis

WANG Hongjun, CHEN Xilong, SUN Xingxing, ZHANG Runlian

PDF(1597 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1597 KB)
Labeled Immunoassays and Clinical Medicine ›› 2023, Vol. 30 ›› Issue (3) : 416-421. DOI: 10.11748/bjmy.issn.1006-1703.2023.03.010
Clinical Investigation

An Evaluation of the Expression of SCC-Ag,PD-L1 and RRM1 on the Efficacy of Chemotherapy in Patients with Intermediate and Advanced Lung Squamous Cell Carcinoma and Analysis of Its Relationship with Prognosis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 30(3): 416-421 https://doi.org/10.11748/bjmy.issn.1006-1703.2023.03.010

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1597 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉